MOSPD3
Motile sperm domain-containing protein 3
Also known as: CDS3, MSPD3_HUMAN, NET30
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75425
- Gene
- MOSPD3
- Ensembl
- ENSG00000106330
- Chromosome
- 7
- Canonical length
- 235 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a multi-pass membrane protein with a major sperm protein (MSP) domain. The deletion of a similar mouse gene is associated with defective cardiac development and neonatal lethality. Alternate transcriptional splice variants, encoding different isoforms, have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>O75425|MOSPD3
1 MRRGAPQDQE LVGPGPPGRG SRGAPPPLGP VVPVLVFPPD LVFRADQRSG PRQLLTLYNP
61 TGTALRFRVL CTAPAKYTVF DAEGYVKPQS CIDIVIRHVA PIPSHYDVQD RFRIELSEEG
121 AEGRVVGRKD ITSILRAPAY PLELQGQPDP APRPGPPAGT PPPTARHFQE HPRQQLATSS
181 FLLFLLTGIV SVAFLLLPLP DELGSQLPQV LHVSLGQKLV AAYVLGLLTM VFLRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MOSPD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- testis: 55 nTPM
- skin: 41 nTPM
- liver: 39 nTPM
- adrenal gland: 36 nTPM
- esophagus: 33 nTPM
- kidney: 23 nTPM
Single-cell type
- late spermatids: 2,548 nCPM
- early spermatids: 378 nCPM
- esophageal apical cells: 194 nCPM
- late primary spermatocytes: 97 nCPM
- esophageal suprabasal cells: 86 nCPM
- parietal cells: 50 nCPM
Immune cell
- T-reg: 57 nTPM
- eosinophil: 40 nTPM
- basophil: 39 nTPM
- NK-cell: 38 nTPM
- MAIT T-cell: 37 nTPM
- memory CD8 T-cell: 37 nTPM
Brain region
- medulla oblongata: 24 nTPM
- amygdala: 22 nTPM
- thalamus: 21 nTPM
- basal ganglia: 20 nTPM
- pons: 20 nTPM
- hypothalamus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MOSPD3 as an antibody target. Whether an autoantibody or antibody against MOSPD3 could matter depends on whether native MOSPD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MOSPD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MOSPD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...